chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pollakiuria, SARS-CoV-2 test
Clinical narrative: Frequent urination for two days following vaccinations.; Stabbing pain in right leg from knee to mid-shin; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) as dose 1, single and administered in arm left (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Clinical depression" (unspecified if ongoing); "Kidney absent" (unspecified if ongoing), notes: Missing left Kidney. Concomitant medication(s) included: VENLAFAXINE HCL; BUPROPION HCL. The following information was reported: POLLAKIURIA (non-serious) with onset 22Apr2021, outcome "recovering", described as "Frequent urination for two days following vaccinations."; PAIN IN EXTREMITY (non-serious) with onset 22Apr2021, outcome "recovering", described as "Stabbing pain in right leg from knee to mid-shin". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pollakiuria, pain in extremity.  Additional information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to vaccination. The events did not result in doctor or other healthcare professional office/clinic, emergency room/ department or urgent care. Since the vaccination, the patient had been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Nausea, Vaccination site pain
Clinical narrative: pain in injection area; bad headache; nauseous; hot flashes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Apr2021 18:30 (Lot number: EW0162) at the age of 27 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLELot Number: ER8734Anatomical site: Arm LeftAdministration time: 18:00), administration date: 07Apr2021, when the patient was 27 years old, for COVID-19 immunization, reaction(s): "Vaccination site pain". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "pain in injection area"; HEADACHE (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "bad headache"; NAUSEA (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "nauseous"; HOT FLUSH (non-serious) with onset 29Apr2021 10:15, outcome "unknown", described as "hot flashes".  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor, Vomiting
Clinical narrative: Vomiting; Shaking; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 54 year-old male patient received bnt162b2 (BNT162B2), administration date 21Apr2021 (Lot number: EW0161) at the age of 54 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "dialysis patient" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VOMITING (non-serious) with onset 22Apr2021 05:00, outcome "recovered" (22Apr2021), described as "Vomiting"; TREMOR (non-serious) with onset 22Apr2021 05:00, outcome "recovered" (22Apr2021), described as "Shaking". The events "vomiting" and "shaking" were evaluated at the emergency room visit.  Additional information: As per reported She said patient was vomiting this morning and shaking. She says the vomiting was around 5:00AM. It was today and it eased off. She says there is no more vomiting, right now patient is not vomiting. She says the shaking was also at 5:00 am. She says this vaccination was for COVID, it was on the (Address). She says COVID 19 EW0161 (Name). She says patient has to go get his second dose on 12May2021. She reads the date of the first dose 21Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Frequent bowel movements, Malaise, Neck pain, SARS-CoV-2 test
Clinical narrative: Thursday morning didnt feel well after i took vicks cold tablet had to move my bowels several times.; Thursday morning didnt feel well after i took vicks cold tablet had to move my bowels several times.; Neck pain is real bad this afternoon.; Tuesday feeling sick .; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 11:00 (Batch/Lot number: unknown) at the age of 55 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Dust allergy" (unspecified if ongoing), notes: Allergy dust; "Osteoporosis" (unspecified if ongoing), notes: Low back osteoporosis; "Arthritis of neck" (unspecified if ongoing), notes: Arthritis neck. Concomitant medication(s) included: VITAMIN D3; VITAMIN C [ASCORBIC ACID]; ZINC. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: UNKNOWN;Anatomical site: Right arm; Administration time :11:45 AM), administration date: 05Apr2021, when the patient was 55 years old, for COVID-19 immunization. The following information was reported: MALAISE (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "Tuesday feeling sick ."; MALAISE (non-serious), FREQUENT BOWEL MOVEMENTS (non-serious) all with onset 29Apr2021, outcome "not recovered" and all described as "Thursday morning didnt feel well after i took vicks cold tablet had to move my bowels several times."; NECK PAIN (non-serious) with onset 29Apr2021, outcome "not recovered", described as "Neck pain is real bad this afternoon.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of malaise, malaise, frequent bowel movements, neck pain.  Additional information: On Tuesday 27Apr2021, the patient experienced feeling sick and felt better all day on Wednesday. On Thursday morning 29Apr2021, the patient did not feel well after taking VICKS cold tablet had to move bowels several times. On Thursday afternoon 29Apr2021, the patient had real bad neck pain. It was unknown whether the event resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the unspecified events which included VICKS cold tablet. The patient underwent lab tests and procedures, which included COVID-19 virus test on 12Apr2021 and the result was negative.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Patient had taken concomitant medication, "Nature bounty 24 hour ester c" for unknown indication and from an unknown date. Patient had not take other vaccine in four weeks of vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis
Clinical narrative: sweating; dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2), administration date 27Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERHIDROSIS (non-serious) with onset 27Apr2021, outcome "unknown", described as "sweating"; DIZZINESS (non-serious) with onset 27Apr2021, outcome "unknown", described as "dizzy".  Additional information: Reporter and husband received first dose this morning, husband sweating and dizzy.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: tooth ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: TOOTHACHE (non-serious), outcome "unknown", described as "tooth ache".  Additional Information: Patient wants to know if she should get her second Covid dose that she has scheduled today, says she has a tooth ache and will need surgery.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Lethargy, Pain in extremity, Peripheral swelling
Clinical narrative: her arms are hurting; my area my arm I am still experiencing a lot of pain and lot of swelling; I am still very very lethargic and dragging around; no energy; her arms are swelled up; it was painful; she had fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 31Mar2021 (Lot number: ER2613) as dose 1, single and administered in arm right, administration date 21Apr2021 (Lot number: EN6204) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE DISCOMFORT (non-serious), outcome "unknown", described as "her arms are hurting"; VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "my area my arm I am still experiencing a lot of pain and lot of swelling"; LETHARGY (non-serious), outcome "unknown", described as "I am still very very lethargic and dragging around"; ASTHENIA (non-serious), outcome "unknown", described as "no energy"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "her arms are swelled up"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "it was painful"; FATIGUE (non-serious), outcome "unknown", described as "she had fatigue".  Additional information: The patient arms are hurting and still swelling after receiving the 2nd dose of Covid vaccine on 21Apr2021. Also experienced the same problem after receiving the 1st shot on 31Mar2021. She mentioned that on the 1st dose her arms swelled up about 4 inches in round and the whole area was swelling and it was painful, she had fatigue and she dragged herself around 2 to 4 days saying she had no energy. 5 to 7 days later, she figured out it was the side effect of the vaccine and it happened the same thing with the 2nd shot.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site swelling
Clinical narrative: her arms are hurting; my area my arm I am still experiencing a lot of pain and lot of swelling; I am still very very lethargic and dragging around; no energy; her arms are swelled up; it was painful; she had fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 31Mar2021 (Lot number: ER2613) as dose 1, single and administered in arm right, administration date 21Apr2021 (Lot number: EN6204) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE DISCOMFORT (non-serious), outcome "unknown", described as "her arms are hurting"; VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "my area my arm I am still experiencing a lot of pain and lot of swelling"; LETHARGY (non-serious), outcome "unknown", described as "I am still very very lethargic and dragging around"; ASTHENIA (non-serious), outcome "unknown", described as "no energy"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "her arms are swelled up"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "it was painful"; FATIGUE (non-serious), outcome "unknown", described as "she had fatigue".  Additional information: The patient arms are hurting and still swelling after receiving the 2nd dose of Covid vaccine on 21Apr2021. Also experienced the same problem after receiving the 1st shot on 31Mar2021. She mentioned that on the 1st dose her arms swelled up about 4 inches in round and the whole area was swelling and it was painful, she had fatigue and she dragged herself around 2 to 4 days saying she had no energy. 5 to 7 days later, she figured out it was the side effect of the vaccine and it happened the same thing with the 2nd shot.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine, Blood creatinine increased, Blood urea, Blood urea increased
Clinical narrative: Creatinine jumped.; BUN and Creatinine jumped; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), administration date: 03Mar2021, for Covid-19 immunization. The following information was reported: BLOOD CREATININE INCREASED (non-serious), outcome "unknown", described as "Creatinine jumped."; BLOOD UREA INCREASED (non-serious), outcome "unknown", described as "BUN and Creatinine jumped". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient experienced adverse reaction after taking both shots of the vaccine. Something has changed in his Lab Work after he can no longer get radiation for cancer.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Dysmenorrhoea, Fatigue, Heavy menstrual bleeding, Menstrual disorder
Clinical narrative: Have been experiencing extreme fatigue and sleepiness since the 2nd dose.; Have been experiencing extreme fatigue and sleepiness since the 2nd dose.; I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks; Uncharacteristic breast tenderness; I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks; I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Apr2021 12:00 (Lot number: ER2613) at the age of 50 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Colitis ulcerative" (unspecified if ongoing); "Dust" (unspecified if ongoing); "menopause" (unspecified if ongoing), notes: I had already begun menopause as I had not had a menstrual cycle for about 5 months. There were no concomitant medications. Vaccination history included: Bnt162b2 (Product: COVID 19, brand=Pfizer,, Lot number:EN6198,, Lot unknown: False,, Administration time:12:00 PM,, Dose number: 1,, Vaccine location: Left arm), administration date: 15Mar2021, when the patient was 51 years old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious), SOMNOLENCE (non-serious) all with onset 07Apr2021, outcome "not recovered" and all described as "Have been experiencing extreme fatigue and sleepiness since the 2nd dose."; MENSTRUAL DISORDER (non-serious), DYSMENORRHOEA (non-serious), HEAVY MENSTRUAL BLEEDING (non-serious) all with onset 07Apr2021, outcome "not recovered" and all described as "I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks"; BREAST TENDERNESS (non-serious) with onset 07Apr2021, outcome "not recovered", described as "Uncharacteristic breast tenderness". Therapeutic measures were not taken as a result of fatigue, somnolence, menstrual disorder, breast tenderness, dysmenorrhoea, heavy menstrual bleeding.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She was 51 and thought she had already begun menopause as she had not had a menstrual cycle for about 5 months. The patient was not diagnosed COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Have been experiencing extreme fatigue and sleepiness since the 2nd dose.; Have been experiencing extreme fatigue and sleepiness since the 2nd dose.; I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks; Uncharacteristic breast tenderness; I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks; I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Apr2021 12:00 (Lot number: ER2613) at the age of 50 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Colitis ulcerative" (unspecified if ongoing); "Dust" (unspecified if ongoing); "menopause" (unspecified if ongoing), notes: I had already begun menopause as I had not had a menstrual cycle for about 5 months. There were no concomitant medications. Vaccination history included: Bnt162b2 (Product: COVID 19, brand=Pfizer,, Lot number:EN6198,, Lot unknown: False,, Administration time:12:00 PM,, Dose number: 1,, Vaccine location: Left arm), administration date: 15Mar2021, when the patient was 51 years old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious), SOMNOLENCE (non-serious) all with onset 07Apr2021, outcome "not recovered" and all described as "Have been experiencing extreme fatigue and sleepiness since the 2nd dose."; MENSTRUAL DISORDER (non-serious), DYSMENORRHOEA (non-serious), HEAVY MENSTRUAL BLEEDING (non-serious) all with onset 07Apr2021, outcome "not recovered" and all described as "I experienced a much more painful, longer and heavier menstrual cycle lasting about 2 weeks"; BREAST TENDERNESS (non-serious) with onset 07Apr2021, outcome "not recovered", described as "Uncharacteristic breast tenderness". Therapeutic measures were not taken as a result of fatigue, somnolence, menstrual disorder, breast tenderness, dysmenorrhoea, heavy menstrual bleeding.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She was 51 and thought she had already begun menopause as she had not had a menstrual cycle for about 5 months. The patient was not diagnosed COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigued; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as single dose for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "fatigued". No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Tenderness
Clinical narrative: little bit of tenderness; Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 07Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TENDERNESS (non-serious), outcome "unknown", described as "little bit of tenderness"; FATIGUE (non-serious), outcome "unknown", described as "Tiredness".   Additional information: The patient received the 1st dose of the Pfizer vaccine on 07APR2021 and he was scheduled to get the 2nd dose on 28Apr2021. He's supposed to work on the 29th and he was hoping if he could take it a day early. He was asking if it will cause any difficulties with the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: mild headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 32 year-old male patient received bnt162b2 (BNT162B2), administration date 28Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious) with onset Apr2021, outcome "recovered" (29Apr2021), described as "mild headache". Therapeutic measures were taken as a result of headache.  Additional information: It was reported that 13 hours after vaccination he had a mild headache. Patient took 2 naproxen (ALEVE) 14 hours after vaccination between 01:00 -02:00. It was reported that it cleared up and was now feeling normal.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Oropharyngeal pain, Pain, Vomiting
Clinical narrative: Sore throat; Diarrhea; Headache; She also has a body ache; Throwing up; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the parent.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 26Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 27Apr2021, outcome "unknown", described as "Sore throat"; DIARRHOEA (non-serious) with onset 27Apr2021, outcome "unknown", described as "Diarrhea"; HEADACHE (non-serious) with onset 27Apr2021, outcome "unknown", described as "Headache"; PAIN (non-serious) with onset Apr2021, outcome "unknown", described as "She also has a body ache"; VOMITING (non-serious) with onset Apr2021, outcome "unknown", described as "Throwing up".  Additional Information: The patient had a side effect after the first dose of the vaccine. The reporter was asking if she should get the second dose. Tuesday (27Apr2021), she developed a sore throat, diarrhea, headache but no fever. She also had a body ache and was throwing up. The reporter was asking if these symptoms were associated with the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Therapeutic response unexpected, Vaccination site pain
Clinical narrative: have a positive reaction to the vaccine so beneficial/Within hours of receiving the vaccine that began to go away; More a soreness from a shot in the muscle; My arm at the site was sore; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "I had a ongoing weakness, pain in my legs" (unspecified if ongoing), notes: I had a ongoing weakness, pain in my legs.; "I had a ongoing weakness, pain in my legs" (unspecified if ongoing), notes: I had a ongoing weakness, pain in my legs. The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "have a positive reaction to the vaccine so beneficial/Within hours of receiving the vaccine that began to go away"; MYALGIA (non-serious), outcome "unknown", described as "More a soreness from a shot in the muscle"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "My arm at the site was sore".  Additional information: The patent state that she didn't know how/who to contact but she did not have any adverse side effects to the vaccine. Her arm at the site was sore you could tell she had gotten a shot, more a soreness from a shot in the muscle. She did feel something in her arm. It wasn't anything bad, no worse than any other shot in the arm. She did have a positive reaction to the vaccine so beneficial to her (don't know what was in it that was so beneficial to her). She had an ongoing weakness, pain in her legs. It was there for several years. Within hours of receiving the vaccine that began to go away, the pain and the weakness (in her legs). She would like to know what was in the vaccine that was so beneficial to her? It had done things for her that can benefit so many other people that had dealt with weakness and pain in their legs. That was why she wanted to tell Pfizer. The patient declined to have the ingredient list sent to her she stated, "Her doctor has that. She had not been to the doctor, but she was sure my doctor has that. She intends to let her doctor. In the past many drugs were developed to treat one thing but was also good treatment for a totally different thing.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Product use issue
Clinical narrative: Caller takes pain relievers/nsaid and wants to know the efficacy of that combination; Caller takes pain relievers/nsaid and wants to know the efficacy of that combination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT USE ISSUE (non-serious), PAIN (non-serious), outcome "unknown" and all described as "Caller takes pain relievers/nsaid and wants to know the efficacy of that combination".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Dizziness, Facial pain, Head discomfort
Clinical narrative: Body aches; Chills; Headache/Extremely bad head; could not lift head off the pillow/her head felt heavier than the rest of her body; slept most of the day yesterday; I feel like I can lose my balance; Nauseous; Dizziness; pain over my left eye brow, is literally killing me, like a nagging pain; This is a spontaneous report received from a non-contactable reporter (Consumer) from medical information team. The reporter is the patient.  A 34-year-old female patient received BNT162B2 (BNT162B2), administration date 27Apr2021 16:00 (Lot number: EW 0172) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (Dose 1, Single, Lot number: EW0150), administration date: 06Apr2021, for COVID-19 immunization. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Body aches"; CHILLS (non-serious), outcome "unknown", described as "Chills"; HEADACHE (non-serious), outcome "unknown", described as "Headache/Extremely bad head"; HEAD DISCOMFORT (non-serious), outcome "unknown", described as "could not lift head off the pillow/her head felt heavier than the rest of her body"; HYPERSOMNIA (non-serious), outcome "unknown", described as "slept most of the day yesterday"; BALANCE DISORDER (non-serious), outcome "unknown", described as "I feel like I can lose my balance "; NAUSEA (non-serious), outcome "unknown", described as "Nauseous"; DIZZINESS (non-serious), outcome "unknown", described as "Dizziness"; FACIAL PAIN (non-serious), outcome "unknown", described as "pain over my left eye brow, is literally killing me, like a nagging pain". Additional Information: The patient stated that on 4pm on Tuesday she got the vaccine. On Wednesday (yesterday), basically all day she experienced body aches, chills, head ache, extremely bad head, she could not lift head off the pillow, her head felt heavier than the rest of her body. She slept most of the day yesterday.  She stated, good news, today she was better, except she felt like she can lose her balance,  and have to sit down. She still has a head ache, but not as bad as yesterday. It was really, extremely bad, felt like her head was in two pieces. She asked if she could take any Tylenol for headache. Today, she was feeling nauseous, it went in and out, but does not last too long. She felt like almost throwing up, but then went away. There are moments where she felt like she wanted to throw up like when just talking to you. The dizziness started today, she was still dizzy and she needed to sit down. She was having pain over her left eyebrow, and was literally killing her, like a nagging pain. Since this happened, she has not been able to complete deadlines.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersomnia, Nausea, Pain
Clinical narrative: Body aches; Chills; Headache/Extremely bad head; could not lift head off the pillow/her head felt heavier than the rest of her body; slept most of the day yesterday; I feel like I can lose my balance; Nauseous; Dizziness; pain over my left eye brow, is literally killing me, like a nagging pain; This is a spontaneous report received from a non-contactable reporter (Consumer) from medical information team. The reporter is the patient.  A 34-year-old female patient received BNT162B2 (BNT162B2), administration date 27Apr2021 16:00 (Lot number: EW 0172) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (Dose 1, Single, Lot number: EW0150), administration date: 06Apr2021, for COVID-19 immunization. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Body aches"; CHILLS (non-serious), outcome "unknown", described as "Chills"; HEADACHE (non-serious), outcome "unknown", described as "Headache/Extremely bad head"; HEAD DISCOMFORT (non-serious), outcome "unknown", described as "could not lift head off the pillow/her head felt heavier than the rest of her body"; HYPERSOMNIA (non-serious), outcome "unknown", described as "slept most of the day yesterday"; BALANCE DISORDER (non-serious), outcome "unknown", described as "I feel like I can lose my balance "; NAUSEA (non-serious), outcome "unknown", described as "Nauseous"; DIZZINESS (non-serious), outcome "unknown", described as "Dizziness"; FACIAL PAIN (non-serious), outcome "unknown", described as "pain over my left eye brow, is literally killing me, like a nagging pain". Additional Information: The patient stated that on 4pm on Tuesday she got the vaccine. On Wednesday (yesterday), basically all day she experienced body aches, chills, head ache, extremely bad head, she could not lift head off the pillow, her head felt heavier than the rest of her body. She slept most of the day yesterday.  She stated, good news, today she was better, except she felt like she can lose her balance,  and have to sit down. She still has a head ache, but not as bad as yesterday. It was really, extremely bad, felt like her head was in two pieces. She asked if she could take any Tylenol for headache. Today, she was feeling nauseous, it went in and out, but does not last too long. She felt like almost throwing up, but then went away. There are moments where she felt like she wanted to throw up like when just talking to you. The dizziness started today, she was still dizzy and she needed to sit down. She was having pain over her left eyebrow, and was literally killing her, like a nagging pain. Since this happened, she has not been able to complete deadlines.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at site of injection/soreness at the injection site; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 (Lot number: ER8733) at the age of 33 years as dose 1, single and administration date 05Apr2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "migraines" (unspecified if ongoing); "IBS" (unspecified if ongoing); "Known allergies: Scented soaps/perfumes" (unspecified if ongoing), notes: known allergies: Scented soaps/perfumes. Concomitant medication(s) included: VIIBRYD; WELLBUTRIN; BUSPAR; TERAZOSIN; VIT D; CLARITIN [CLARITHROMYCIN]. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05Apr2021, outcome "recovered" (2021), described as "Pain at site of injection/soreness at the injection site". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: patient had not received other vaccine in four weeks. Patient not had covid prior vaccination and patient was not tested to covid post vaccination. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Vaccination site pain
Clinical narrative: Soreness at the injection site; chills; very tired; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0165) at the age of 33 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known_allergies:Scented soaps/perfumes" (unspecified if ongoing); "Irritable bowel syndrome" (unspecified if ongoing); "Migraine" (unspecified if ongoing); "Anxiety/depression" (unspecified if ongoing); "depression" (unspecified if ongoing). Concomitant medication(s) included: VIIBRYD; WELLBUTRIN; BUSPAR; TERAZOSIN; VITAMIN D. Vaccination history included: Bnt162b2 (Dose 1, Single; Manufacturer unknown;, Lot Number: ER8733; Anatomical site: Left Arm), administration date: 05Apr2021, when the patient was 33 years old, for COVID-19 immunization, reaction(s): "soreness at the injection site". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "Soreness at the injection site"; CHILLS (non-serious) with onset 2021, outcome "recovered" (2021), described as "chills"; FATIGUE (non-serious) with onset 2021, outcome "recovered" (2021), described as "very tired". Therapeutic measures were not taken as a result of vaccination site pain, chills, fatigue.  Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Peripheral swelling
Clinical narrative: both of my feet are swollen, the right foot is swollen and the left foot is swollen; these knees are swollen.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.   A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0164) at the age of 73 years as single dose for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 26Apr2021, outcome "unknown", described as "both of my feet are swollen, the right foot is swollen and the left foot is swollen"; JOINT SWELLING (non-serious) with onset 26Apr2021, outcome "unknown", described as "these knees are swollen.". Therapeutic measures were not taken as a result of peripheral swelling.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021499344 Same reporter/drug ,different patient
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site pain
Clinical narrative: Tingling in index finger; Pain at injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jan2021 (Lot number: EL9209) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Type 2 Diabetes" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; FISH OIL; CHOLECALCIFEROL. The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "Tingling in index finger"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Pain at injection site".  Additional information: First dose had pain at injection site with approximately a 4-5 inch radius .  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: began experiencing chills and aches; began experiencing chills and aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 14Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), PAIN (non-serious) all with onset 14Apr2021, outcome "unknown" and all described as "began experiencing chills and aches".  Additional information: After receiving the first dose of the vaccine on 14Apr2021, the patient began experiencing chills and aches within 24 hours. The patient advised that it felt worse than with COVID.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Tasted injection had immediate dizzy feeling that passed quickly on both injection dates; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Apr2021 (Batch/Lot number: unknown) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "ulcerated colitis" (unspecified if ongoing); "current arthritis" (unspecified if ongoing); "Chemotherapy" (unspecified if ongoing), notes: colon cancer chemotherapy. There were no concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "Tasted injection had immediate dizzy feeling that passed quickly on both injection dates".  Additional Information: The patient previously took Latex for unknown indication on unknown date. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen intraclavicular lymph node on right side after first vaccine in right arm.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 31-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01Apr2021 16:45 (Batch/Lot number: unknown) at the age of 31 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Shellfish" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 05Apr2021, outcome "recovering", described as "Swollen intraclavicular lymph node on right side after first vaccine in right arm.". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional Information The reason was unknown for Lot: Not available/provided to reporter at the time of report completion. The hospital was the Facility type.The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not have any AE(s) following prior vaccinations. No covid tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: she is having colds.; This is a spontaneous report received from a contactable reporter (Consumer) for a sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "unknown", described as "she is having colds.".  Additional Information: The patient won't be able to get her scheduled second dose of vaccine today (26Apr2021) because she was having colds. She could not recall when was her first dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Gastrointestinal disorder, Nausea
Clinical narrative: gastrointestinal problems; nauseous; diarrhea; This is a spontaneous report received from a contactable reporter (Consumer).  A female patient received BNT16B2 (BNT162B2), administered in arm left, administration date 15Apr2021 13:15 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single, Vaccine Location: Left arm, Time: 01:15PM.), administration date: 25Mar2021, for Covid-19 immunisation. The following information was reported: GASTROINTESTINAL DISORDER (non-serious) with onset 17Apr2021, outcome "unknown", described as "gastrointestinal problems"; NAUSEA (non-serious) with onset 17Apr2021, outcome "unknown", described as "nauseous"; DIARRHOEA (non-serious) with onset 17Apr2021, outcome "unknown", described as "diarrhea". The events "gastrointestinal problems", "nauseous" and "diarrhea" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of gastrointestinal disorder, nausea, diarrhoea. Additional Information: The patient's age was reported as 50 (units unknown). The patient did not receive other vaccine in four weeks and has not received other medications in two weeks. The reporter and the patient got both of their vaccines at the same time/place. On their second dose they had normal side effects that went away after two days, but they have had gastrointestinal problems since, going on two weeks now. They were both nauseous and eating anything beside the BRAT diet made them feel even worse. The patient has also had diarrhea as well and they were contacting their doctor tomorrow to check it out. The patient has not been diagnosed with COVID prior vaccination and has not been tested for COVID post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: Unexplained prolonged twitching in neck.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administration date Apr2021 (Lot number: Unknown) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCLE TWITCHING (non-serious) with onset Apr2021, outcome "recovered", described as "Unexplained prolonged twitching in neck.". Therapeutic measures were not taken as a result of muscle twitching.  Additional information: Patient had never experienced this before in his life. It occurred 6 days after receiving the first dose of the Pfizer Covid-19 vaccine. Patient is a very healthy adult male with no significant medical issues in the past. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown, the patient was diagnosed with COVID-19 prior to vaccination. It was unknown, since the vaccination, the patient been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.